The structural basis of molecular genetic deletions: An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 383-391

  Brat, Daniel J ^a   Hahn, Stephan A ^a   Griffin, Constance A ^a   Yeo, Charles J ^a   Kern, Scott E ^a   Hruban, Ralph H ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ISOCHROMOSOME; KARYOTYPE; MOLECULAR GENETICS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ALLELES; CYTOGENETICS; GENE DELETION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; KARYOTYPING; MIDDLE AGED; MOLECULAR BIOLOGY; PANCREATIC NEOPLASMS;

EID: 0031035227     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992, 326:455-465
2. Parker SL, Tong T, Beiden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 1996, 46:5-27
3. Hruban RH, van der Riet P, Erozan YS, Sidransky D: Brief report: molecular biology and the early detection of carcinoma of the bladder-the case of Hubert H. Humphrey, N Engl J Med 1994, 330:1276-1278
4. DiGiuseppe JA, Hruban RH, Offerhaus GJA, Clement MJ, van den Berg FM, Cameron JL, van Mansfeld ADM: Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma, Am J Pathol 1994, 144:889-895
5. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL: K-ras oncogene activation in adenocarcinoma of the human pancreas, A study of 82 carcinomas using a combination of mutantenriched polymerase chain reaction'analysis and allele-specific oligonucleo-tide hybridization. Am J Pathol 1993, 143:545-554
6. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma, Cancer Res 1993, 53: 2472-2474
7. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia, Cancer Res 1994, 54:3568-3573
8. Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-lssa F, Yeo CJ: Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes & Cancer 1994, 9:93-100
9. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ: Consistent chromosome abnormalities in adenocarcinoma of the pancreas, Cancer Res 1995, 55:2394-2399
10. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, daCosta LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995, 55:4670-4675
11. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, daCosta LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-353
12. Caldas C, Hahn SA, daCosta LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1 ) gene in pancreatic adenocarcinoma. Nat Genet 1994, 8:27-32
13. Schutte M, daCosta LT, Hahn SA, Moskaluk C, Hoque ATMS, Rozenblum E, Weinstein CL, Bitner M, Meltzer PS, Trent JM, Yeo CJ, Hruban RH, Kern SE: Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Prop Natl Acad Sci USA 1995, 92:5950-5954
14. Mitelman F (Ed): ISCN 1995: An International System for Human Cytogenetic Nomenclature. Basel, Karger, 1995
15. Matise TC, Perlin M, Chakravarti A: Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet 1994, 6:384-390
16. NIH/CEPH Collaborative Mapping Group: A comprehensive genetic linkage map of the human genome. Science 1992, 258:67-86
17. Buetow KH, Weber JL, Ludwigsen S, Scherpbier-Heddema T, Duyk GM, Sheffield VC, Wang Z, Murray JC: Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet 1994, 6:391-393
18. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M: A secondgeneration linkage map of the human genome. Nature 1992, 359:794-801
19. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Keisell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Pete J, Devilee P, Cornellsse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378:789-763
20. Hahn SA, Hoque ATMS, Moskaluk CA, daCosta LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE: Homozygous deletion map at 18q21.1 in pancreatic cancer, Cancer Res 1996, 56:490-494
21. Feron ER, Cho KR, Nigro JM, Kern SE, Simons JW, Ruppert JM, Hamilton SR, Preisinger AP, Thomas G, Kinsler KW, Vogelstein B: Identification of a chromosome 18q gene that is altered in colorectal cancers, Science 1990, 247:49-56
22. Biegel JA, Burk CD, Parmiter AH, Emanuel BS: Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor. Genes Chromosomes & Cancer 1992, 5:104-108
23. Bello JM, deCampos JM, Vaquero J, Kusak ME, Sarasa JL, Pestana A, Rey JA: Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes & Cancer 1994, 9:33-41
24. Parsa NZ, Gaidano G, Mukherjee, Haupstschein RS, Lenoir G, Dalla-Favera R, Chaganti RSK: Cytogenetic and molecular analysis of 6q deletions in Burkitts's lymphoma cell lines. Genes Chromosomes & Cancer 1994, 9:13-18
25. Redston MS, Caldas C, Seymour AB, Hruban RH, daCosta L, Yeo CJ, Kern SE: p53 mutations in pancreatic carcinoma and evidence of common involvement of hemocopolymer tracts in DMA microdeletions, Cancer Res 1994, 54:3025-3033
26. Pellegata S, Sessa F, Renault B, Bonato M, Leone BE, Solcia E, Ranzani GN: K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions, Cancer Res 1994, 54:1556-1560
27. Schutte M, Hruban RH, Hedrick L, Nadasy GM, Weinstein GL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero R, Meltzer PS, Vogelstein B, Hahn SA, Kern SE: Tissue-restriction in DPC4 gene alterations. Cancer Res 1996, 56:2527-2530
28. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 1983, 305:779-784
29. de Sepulveda P, Guenet JL, and Panthier, JJ: Phenotypic reversions at the w/kit locus mediated by mitotic recombination in mice, Mol Cell Biol 1995, 15:5898-5905